Impel NeuroPharma Announces Publication of Pivotal Phase 3, Open-Label Stop 301 Study of INP104 (TRUDHESA™) for Treatment of Acute Migraine in the Journal Headache
Study Shows TRUDHESA™ Was Well Tolerated and Delivered Rapid, Consistent Symptom Relief Exploratory Patient-Reported Outcomes…
Fuentes Zapata LLC Announces the Release of “The Remote Marketer’s Toolkit”
Sheds For Less Direct Celebrates 20 Years as America’s Original Nationwide Shed Dealer
NightCafe Studio Leverages Google Cloud to Power AI Art Creation for 25 Million Users with a Four-Person Team
TEN Framework Celebrates One-Year Anniversary as Open-Source Infrastructure for Real-Time Conversational AI Development
Safety Training Seminars Opens New CPR Certification School in San Mateo, CA